Geneos Therapeutics Announces Positive Phase 1/2 Data for GT-30 Trial of Personalized Therapeutic Cancer Vaccine

/PRNewswire/ -- Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines (PTCVs),...

Related Keywords

Philadelphia ,Pennsylvania ,United States ,San Diego ,California ,American ,Ildiko Csiki ,Niranjan Sardesai ,American Association For Cancer Research ,Neoantigen Vaccine ,Advanced Hepatocellular Carcinoma ,Cancer Research ,Annual Meeting ,Geneos Therapeutics ,Nc ,